Biomarin Pharmaceutical Inc.
H‑1B Sponsor Verified
Yes. Biomarin Pharmaceutical Inc. filed 161 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2019–2026, including 4 so far in 2026. The average H-1B salary is $128,326 and the most sponsored role is Scientist 1, Gene Therapy Research.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: May 28, 2026.
LinkedIn ↗Latest Year Filings
4
In 2026
↗ Filter by year
Total H‑1B Filings
161
Since 2020
↗ View records
Avg Annual Salary
$128,326
All years combined
↗ View chart
Top Role
Scientist 1, Gene Therapy Research
↗ Click to filter
Filing trend
H‑1B filings by year for Biomarin Pharmaceutical Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 4 | $133,713 |
| 2025 | 31 | $143,659 |
| 2024 | 25 | $118,749 |
| 2023 | 24 | $126,504 |
| 2022 | 29 | $131,120 |
| 2021 | 26 | $125,342 |
| 2020 | 20 | $118,351 |
| 2019 | 2 | $119,538 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary